RARE Ultragenyx Pharmaceutical Inc.
Nasdaq · SEC CIK 1515673 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.95M 25 sales by 9 insiders
- Filings on record
- 172 since 2021-07-08, latest 2026-09-15 18:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Horn Howard | CFO | — | $1.33M |
| KAKKIS EMIL D | Pres, CEO, Dir | — | $1.24M |
| Parschauer Karah Herdman | EVP, CLO | — | $487.9K |
| Harris Erik | EVP, Chief Commercial Off | — | $240.3K |
| Pinion John Richard | See Remarks | — | $228.7K |
| Crombez Eric | EVP, Chief Medical Off | — | $168.8K |
| SULIMAN SHEHNAAZ | Dir | — | $144.2K |
| Huizenga Theodore Alan | SVP, CAO | — | $59.8K |
| Sanders Corazon (Corsee) D. | Dir | — | $50.1K |
| Ray Amrit | Dir | — | — |
Transactions 235
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-20 | 2024-06-18 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +5,345 | 12.6K | +74% | $0 |
| D | 2024-06-20 | 2024-06-18 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +5,345 | 25.1K | +27% | $0 |
| T | 2024-06-12 | 2024-06-12 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.00 | -9,806 | 58.0K | -14% | -$441.3K |
| T | 2024-06-10 | 2024-06-10 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $41.10 | -1,737 | 7,248 | -19% | -$71.4K |
| 2024-05-03 | 2024-05-02 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $43.66 | -354 | 48.4K | -0.7% | -$15.5K | |
| 2024-04-19 | 2024-04-18 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $44.10 | -142 | 48.8K | -0.3% | -$6,262 | |
| 2024-04-18 | 2024-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $42.31 | -14 | 41.4K | -0.0% | -$592.34 | |
| 2024-03-12 | 2024-03-11 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $49.93 | -11.5K | 252.8K | -4% | -$574.6K | |
| MT | 2024-03-11 | 2024-03-07 | RARE | Fust Matthew K | Dir | S - Sale | $50.88 | -12.2K | 14.9K | -45% | -$620.4K |
| DM | 2024-03-05 | 2024-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +41.6K | 563.9K | +8% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $53.69 | -17.4K | 560.8K | -3% | -$935.1K |
| D | 2024-03-05 | 2024-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $53.76 | -4,768 | 67.2K | -7% | -$256.3K |
| DM | 2024-03-05 | 2024-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +20.4K | 70.7K | +40% | $0 |
| DM | 2024-03-05 | 2024-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +18.8K | 83.5K | +29% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Huang Dennis Karl | See Remarks | F - Tax | $53.69 | -470 | 83.0K | -0.6% | -$25.2K |
| D | 2024-03-05 | 2024-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +13.9K | 41.8K | +50% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $53.69 | -121 | 41.7K | -0.3% | -$6,496 |
| D | 2024-03-05 | 2024-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $53.76 | -341 | 41.4K | -0.8% | -$18.3K |
| D | 2024-03-05 | 2024-03-01 | RARE | Horn Howard | CFO | A - Grant | $0.00 | +19.4K | 99.8K | +24% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Pinion John Richard | See Remarks | S - Sale | $53.76 | -4,173 | 89.3K | -4% | -$224.3K |
| D | 2024-03-05 | 2024-03-01 | RARE | Pinion John Richard | See Remarks | F - Tax | $53.69 | -60 | 93.4K | -0.1% | -$3,221 |
| DM | 2024-03-05 | 2024-03-01 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +18.8K | 93.5K | +25% | $0 |
| DM | 2024-03-05 | 2024-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +18.8K | 265.6K | +8% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $53.76 | -1,011 | 264.3K | -0.4% | -$54.4K |
| D | 2024-03-05 | 2024-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | F - Tax | $53.69 | -274 | 265.3K | -0.1% | -$14.7K |
| D | 2024-03-05 | 2024-03-01 | RARE | Crombez Eric | EVP, Chief Medical Off | A - Grant | $0.00 | +19.4K | 49.9K | +64% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Crombez Eric | EVP, Chief Medical Off | S - Sale | $53.76 | -1,238 | 48.9K | -2% | -$66.6K |
| DM | 2024-03-05 | 2024-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +18.8K | 69.8K | +37% | $0 |
| D | 2024-03-05 | 2024-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $53.76 | -3,756 | 67.3K | -5% | -$201.9K |
| 2024-02-08 | 2024-02-07 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $45.00 | -30.0K | 539.8K | -5% | -$1.35M | |
| D | 2024-01-02 | 2024-01-02 | RARE | Huizenga Theodore Alan | SVP, CAO | M - OptEx | $21.00 | +3,000 | 27.9K | +12% | +$63.0K |
| D | 2024-01-02 | 2023-12-20 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +1,000 | 24.6K | +4% | $0 |
| 2024-01-02 | 2023-12-29 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $47.87 | -30.0K | 569.8K | -5% | -$1.44M | |
| D | 2023-10-24 | 2023-10-23 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale+OE | $32.78 | -39.9K | 246.9K | -14% | -$1.31M |
| D | 2023-10-24 | 2023-10-23 | RARE | Kassberg Thomas Richard | EVP, CBO | M - OptEx | $6.86 | +39.9K | 286.7K | +16% | +$273.6K |
| D | 2023-10-23 | 2023-10-19 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | M - OptEx | $6.86 | +47.9K | 647.0K | +8% | +$328.3K |
| D | 2023-10-23 | 2023-10-19 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale+OE | $33.52 | -47.9K | 599.7K | -7% | -$1.60M |
| D | 2023-10-10 | 2023-10-09 | RARE | Horn Howard | CFO | A - Grant | $0.00 | +80.4K | 80.3K | New | $0 |
| D | 2023-09-11 | 2023-09-07 | RARE | Huizenga Theodore Alan | SVP, CAO | M - OptEx | $21.00 | +2,000 | 25.8K | +8% | +$42.0K |
| DM | 2023-09-11 | 2023-09-07 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale+OE | $40.80 | -2,163 | 23.6K | -8% | -$88.2K |
| 2023-09-06 | 2023-09-05 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $37.96 | -6,000 | 51.3K | -10% | -$227.8K | |
| M | 2023-09-06 | 2023-09-01 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $37.15 | -970 | 23.9K | -4% | -$36.0K |
| 2023-06-30 | 2023-06-30 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $46.76 | -585 | 8,985 | -6% | -$27.4K | |
| 2023-06-21 | 2023-06-19 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $48.20 | -305 | 57.3K | -0.5% | -$14.7K | |
| D | 2023-06-09 | 2023-06-07 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +3,860 | 19.7K | +24% | $0 |
| D | 2023-06-09 | 2023-06-08 | RARE | Sanders Corazon (Corsee) D. | Dir | S - Sale | $51.65 | -1,485 | 9,570 | -13% | -$76.7K |
| D | 2023-06-09 | 2023-06-07 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +3,860 | 11.1K | +54% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Fust Matthew K | Dir | D - Sale to Iss | $51.82 | -3,300 | 27.1K | -11% | -$171.0K |
| D | 2023-06-09 | 2023-06-07 | RARE | Fust Matthew K | Dir | A - Grant | $0.00 | +3,860 | 30.4K | +15% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | WELCH DANIEL G | Dir | A - Grant | $0.00 | +3,860 | 21.6K | +22% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +3,860 | 14.9K | +35% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +3,860 | 12.3K | +46% | $0 |
| D | 2023-06-09 | 2023-06-07 | RARE | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +3,860 | 21.6K | +22% | $0 |
| 2023-05-19 | 2023-05-18 | RARE | Pinion John Richard | See Remarks | S - Sale | $50.00 | -2,012 | 74.7K | -3% | -$100.6K | |
| D | 2023-05-10 | 2023-05-09 | RARE | Huizenga Theodore Alan | SVP, CAO | M - OptEx | $21.00 | +3,000 | 30.7K | +11% | +$63.0K |
| 2023-05-05 | 2023-05-04 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.00 | -4,378 | 52.0K | -8% | -$197.0K | |
| D | 2023-05-02 | 2023-05-01 | RARE | Crombez Eric | EVP, Chief Medical Off | A - Grant | $0.00 | +4,658 | 30.5K | +18% | $0 |
| 2023-04-18 | 2023-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | D - Sale to Iss | $38.20 | -181 | 27.5K | -0.7% | -$6,914 | |
| 2023-04-18 | 2023-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | F - Tax | $38.20 | -14 | 27.7K | -0.1% | -$534.80 | |
| 2023-03-03 | 2023-03-01 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | A - Grant | $0.00 | +2,663 | 50.6K | +6% | $0 | |
| 2023-03-03 | 2023-03-01 | RARE | Bedrosian Camille L | EVP, Chief Medical Off | S - Sale | $45.25 | -3,881 | 46.7K | -8% | -$175.6K | |
| DM | 2023-03-03 | 2023-03-01 | RARE | Pinion John Richard | See Remarks | A - Grant | $0.00 | +24.7K | 61.9K | +66% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Pinion John Richard | See Remarks | S - Sale | $45.26 | -3,755 | 80.2K | -4% | -$170.0K |
| D | 2023-03-03 | 2023-03-01 | RARE | Pinion John Richard | See Remarks | D - Sale to Iss | $45.65 | -4,014 | 76.2K | -5% | -$183.2K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | A - Grant | $0.00 | +24.7K | 38.8K | +174% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $45.25 | -3,664 | 57.3K | -6% | -$165.8K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | A - Grant | $0.00 | +24.7K | 37.1K | +198% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $45.25 | -3,161 | 56.1K | -5% | -$143.0K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | A - Grant | $0.00 | +24.7K | 252.2K | +11% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | D - Sale to Iss | $45.65 | -3,394 | 246.9K | -1% | -$154.9K |
| D | 2023-03-03 | 2023-03-01 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $45.27 | -1,968 | 250.3K | -0.8% | -$89.1K |
| DM | 2023-03-03 | 2023-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | A - Grant | $0.00 | +54.9K | 569.4K | +11% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | F - Tax | $45.65 | -16.1K | 599.2K | -3% | -$736.8K |
| DM | 2023-03-03 | 2023-03-01 | RARE | Huang Dennis Karl | See Remarks | A - Grant | $0.00 | +24.7K | 53.7K | +85% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Huang Dennis Karl | See Remarks | S - Sale | $45.65 | -389 | 75.3K | -0.5% | -$17.8K |
| D | 2023-03-03 | 2023-03-01 | RARE | Huang Dennis Karl | See Remarks | D - Sale to Iss | $45.65 | -10.6K | 64.7K | -14% | -$483.8K |
| D | 2023-03-03 | 2023-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +7,590 | 23.1K | +49% | $0 |
| D | 2023-03-03 | 2023-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | D - Sale to Iss | $45.65 | -1,333 | 21.7K | -6% | -$60.9K |
| D | 2023-03-03 | 2023-03-01 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $45.65 | -100 | 23.0K | -0.4% | -$4,565 |
| 2023-03-02 | 2023-02-28 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $43.40 | -639 | 15.6K | -4% | -$27.7K | |
| 2023-01-03 | 2022-12-30 | RARE | KAKKIS EMIL D | Pres, CEO, Dir | S - Sale | $45.57 | -19.6K | 541.1K | -3% | -$892.4K | |
| 2022-12-22 | 2022-12-21 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $43.96 | -2,031 | 16.2K | -11% | -$89.3K | |
| 2022-10-17 | 2022-10-14 | RARE | Dier Mardi | CFO, EVP | S - Sale | $40.16 | -1,629 | 66.7K | -2% | -$65.4K | |
| 2022-10-14 | 2022-10-12 | RARE | Dier Mardi | CFO, EVP | S - Sale | $38.22 | -3,484 | 68.3K | -5% | -$133.2K | |
| 2022-09-19 | 2022-09-16 | RARE | Dier Mardi | CFO, EVP | A - Grant | $0.00 | +20.0K | 71.8K | +39% | $0 | |
| 2022-09-08 | 2022-09-01 | RARE | Huizenga Theodore Alan | SVP, CAO | A - Grant | $0.00 | +1,000 | 18.1K | +6% | $0 | |
| D | 2022-06-29 | 2022-06-24 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +3,300 | 7,195 | +85% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | WELCH DANIEL G | Dir | A - Grant | $0.00 | +3,300 | 17.7K | +23% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Dunsire Deborah | Dir | A - Grant | $0.00 | +3,300 | 15.9K | +26% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Fust Matthew K | Dir | A - Grant | $0.00 | +3,300 | 26.5K | +14% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Ekman Lars | Dir | A - Grant | $0.00 | +3,300 | 17.7K | +23% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | SULIMAN SHEHNAAZ | Dir | A - Grant | $0.00 | +3,300 | 11.0K | +43% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | NARACHI MICHAEL | Dir | A - Grant | $0.00 | +3,300 | 17.7K | +23% | $0 |
| D | 2022-06-28 | 2022-06-24 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +3,300 | 8,420 | +64% | $0 |
| 2022-06-22 | 2022-06-19 | RARE | Harris Erik | EVP, Chief Commercial Off | S - Sale | $54.78 | -295 | 36.2K | -0.8% | -$16.2K | |
| D | 2022-04-22 | 2022-04-19 | RARE | Ray Amrit | Dir | A - Grant | $0.00 | +5,120 | 5,120 | New | $0 |
| 2022-04-19 | 2022-04-16 | RARE | Huizenga Theodore Alan | SVP, CAO | S - Sale | $84.55 | -132 | 16.9K | -0.8% | -$11.2K | |
| 2022-03-15 | 2022-03-11 | RARE | Kassberg Thomas Richard | EVP, CBO | S - Sale | $67.01 | -10.3K | 227.6K | -4% | -$688.9K | |
| 2022-03-08 | 2022-03-07 | RARE | Parschauer Karah Herdman | EVP, CLO | S - Sale | $62.95 | -5,140 | 34.4K | -13% | -$323.6K | |
| D | 2022-03-08 | 2022-03-04 | RARE | Fust Matthew K | Dir | M - OptEx | $40.37 | +7,500 | 23.2K | +48% | +$302.8K |
Purchase Sale Sale after option exercise All abbreviations